Vanda Pharmaceuticals Announces Participation in the Mizuho Neuro & Ophthalmology Summit 2025
Vanda Pharmaceuticals (Nasdaq: VNDA) announced its upcoming participation in investor meetings at the Mizuho Neuro & Ophthalmology Summit 2025. The event will take place in New York City on Wednesday, May 21, 2025. This conference provides an opportunity for Vanda to engage with investors and discuss their developments in the neurological and ophthalmological therapeutic areas.
Vanda Pharmaceuticals (Nasdaq: VNDA) ha annunciato la sua prossima partecipazione a incontri con investitori durante il Mizuho Neuro & Ophthalmology Summit 2025. L'evento si terrà a New York City mercoledì 21 maggio 2025. Questa conferenza rappresenta un'occasione per Vanda di interagire con gli investitori e discutere i propri progressi nelle aree terapeutiche neurologiche e oftalmologiche.
Vanda Pharmaceuticals (Nasdaq: VNDA) anunció su próxima participación en reuniones con inversores en la Cumbre Mizuho Neuro & Ophthalmology 2025. El evento tendrá lugar en Nueva York el miércoles 21 de mayo de 2025. Esta conferencia ofrece una oportunidad para que Vanda se reúna con inversores y discuta sus avances en las áreas terapéuticas neurológicas y oftalmológicas.
Vanda Pharmaceuticals (나스닥: VNDA)가 2025년 미즈호 신경 및 안과 서밋에서 투자자 미팅에 참여할 예정임을 발표했습니다. 이 행사는 2025년 5월 21일 수요일, 뉴욕시에서 개최됩니다. 이번 회의는 Vanda가 투자자들과 소통하고 신경학 및 안과 치료 분야의 개발 현황을 논의할 수 있는 기회를 제공합니다.
Vanda Pharmaceuticals (Nasdaq : VNDA) a annoncé sa prochaine participation aux rencontres avec les investisseurs lors du Mizuho Neuro & Ophthalmology Summit 2025. L'événement se déroulera à New York City le mercredi 21 mai 2025. Cette conférence offre à Vanda une occasion d'échanger avec les investisseurs et de présenter ses avancées dans les domaines thérapeutiques neurologiques et ophtalmologiques.
Vanda Pharmaceuticals (Nasdaq: VNDA) gab seine bevorstehende Teilnahme an Investorenmeetings beim Mizuho Neuro & Ophthalmology Summit 2025 bekannt. Die Veranstaltung findet am Mittwoch, den 21. Mai 2025 in New York City statt. Diese Konferenz bietet Vanda die Möglichkeit, mit Investoren in Kontakt zu treten und über ihre Entwicklungen in den neurologischen und ophthalmologischen Therapiegebieten zu sprechen.
- None.
- None.
About Vanda Pharmaceuticals Inc.
Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on X @vandapharma.
Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com
Jim Golden / Jack Kelleher / Dan Moore
Collected Strategies
VANDA-CS@collectedstrategies.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-in-the-mizuho-neuro--ophthalmology-summit-2025-302458143.html
SOURCE Vanda Pharmaceuticals Inc.
FAQ
When is Vanda Pharmaceuticals (VNDA) participating in the Mizuho Neuro & Ophthalmology Summit 2025?
Where is the Mizuho Neuro & Ophthalmology Summit 2025 being held?
What type of meetings will VNDA participate in at the Mizuho Summit 2025?
What is the stock symbol for Vanda Pharmaceuticals?
